Prosecution Insights
Last updated: August 07, 2026

UNIVERSITE PARIS CITE

10 pending office actions • 8 art units • 10 examiners • 0 of 10 (0%) have an AI response strategy ready • 5 patents granted in the last 365 days

Portfolio Summary

10
Total Pending OAs
7
Non-Final OAs
3
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

0
Overdue
0
Due this week
1
Due this month
1
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

7
Hard (70%)
3
Medium (30%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other1 (10%)
§103 only2 (20%)
Double-patenting + other1 (10%)
Multi-statute (no §101)6 (60%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

7
Life Sciences
70% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
1
Mechanical / Eng
10% of docket
2
Business / Other
20% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

100 h
Manual time on pending OAs
20 h
Time saved (low, 20%)
35 h
Time saved (mid, 35%)
0.9 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
GROSS, JASON PATRICK 1 63.6% +48.3%
BARRON, SEAN C 1 53.3% +30.6%
MCDOWELL, BRIAN E 1 74.2% +30.4%
PERSONS, JENNA L 1 50.0% +60.0%
BUTTICE, AUDREY L 1 47.1% +26.0%
BRADLEY, CHRISTINA 1 62.8% +33.2%
BARSKY, JARED 1 50.3% +23.1%
LUSI, ELLIS FOLLETT 1 64.3% +52.8%
BAKSHI, PANCHAM 1 77.0% +30.2%
KOLTONOW, ANDREW ROBERT 1 46.3% +33.8%

Hard Cases (7)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 7 ordered by deadline are shown.

App #TitleExaminerDue in
18700200 GIANT ORGANELLES RECOVERY AND USE THEREOF BARRON, SEAN C 21d
18032817 METHOD FOR EVALUATING THE MECHANOBIOLOGICAL PROPERTIES OF A CELL ELEMENT LUSI, ELLIS FOLLETT 34d
18684600 NOVEL SEROTONIN DERIVATIVES AND THEIR USES FOR TREATING IRON-ASSOCIATED DISORDERS MCDOWELL, BRIAN E
18575442 METHODS FOR IMPROVING RELAXATION OF STRIATED MYOCYTES PERSONS, JENNA L
18571893 USE OF IL-36 INHIBITORS FOR THE TREATMENT OF NETHERTON SYNDROME BUTTICE, AUDREY L
18552054 TREM-1 INHIBITORS FOR THE TREATMENT OF MARFAN SYNDROME BRADLEY, CHRISTINA
17797682 REVERSE ELECTRO-OSMOTIC FILTRATION SYSTEM AND USES THEREOF KOLTONOW, ANDREW ROBERT

Interview Candidates (10)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18700200 GIANT ORGANELLES RECOVERY AND USE THEREOF BARRON, SEAN C 21d
18032817 METHOD FOR EVALUATING THE MECHANOBIOLOGICAL PROPERTIES OF A CELL ELEMENT LUSI, ELLIS FOLLETT 34d
19078397 Efficient Magnetic Resonance Elastography using Interleaved Motion Encoding GROSS, JASON PATRICK
18684600 NOVEL SEROTONIN DERIVATIVES AND THEIR USES FOR TREATING IRON-ASSOCIATED DISORDERS MCDOWELL, BRIAN E
18575442 METHODS FOR IMPROVING RELAXATION OF STRIATED MYOCYTES PERSONS, JENNA L
18571893 USE OF IL-36 INHIBITORS FOR THE TREATMENT OF NETHERTON SYNDROME BUTTICE, AUDREY L
18552054 TREM-1 INHIBITORS FOR THE TREATMENT OF MARFAN SYNDROME BRADLEY, CHRISTINA
18266499 EMBOLIZING EMULSION FOR TREATMENT OF INFLAMMATORY HYPERVASCULARIZATION ASSOCIATED WITH MUSCULOSKELETAL DISORDERS BARSKY, JARED

Top Art Units

Art UnitApps
3797 1
1653 1
1624 1
1654 1
1628 1
1677 1
1623 1
1700 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19078397 Efficient Magnetic Resonance Elastography using Interleaved Motion Encoding GROSS, JASON PATRICK 3797 §103 Non-Final OA Pending Mar 13, 2025
18700200 GIANT ORGANELLES RECOVERY AND USE THEREOF BARRON, SEAN C 1653 §103§112 Final Rejection 21d Pending Apr 10, 2024
18684600 NOVEL SEROTONIN DERIVATIVES AND THEIR USES FOR TREATING IRON-ASSOCIATED DISORDERS MCDOWELL, BRIAN E 1624 §102§112 Non-Final OA Pending Feb 16, 2024
18575442 METHODS FOR IMPROVING RELAXATION OF STRIATED MYOCYTES PERSONS, JENNA L §101§102§112 Non-Final OA Pending Dec 29, 2023
18571893 USE OF IL-36 INHIBITORS FOR THE TREATMENT OF NETHERTON SYNDROME BUTTICE, AUDREY L §102§103§112 Non-Final OA Pending Dec 19, 2023
18552054 TREM-1 INHIBITORS FOR THE TREATMENT OF MARFAN SYNDROME BRADLEY, CHRISTINA 1654 §103§112 Non-Final OA Pending Sep 22, 2023
18266499 EMBOLIZING EMULSION FOR TREATMENT OF INFLAMMATORY HYPERVASCULARIZATION ASSOCIATED WITH MUSCULOSKELETAL DISORDERS BARSKY, JARED 1628 §103 Final Rejection Pending Jun 09, 2023
18032817 METHOD FOR EVALUATING THE MECHANOBIOLOGICAL PROPERTIES OF A CELL ELEMENT LUSI, ELLIS FOLLETT 1677 §103§112 Non-Final OA 34d Pending Apr 20, 2023
18001184 FUCOIDAN-FUNCTIONALIZED POLYSACCHARIDE PARTICLES WITH T-PA FOR TARGETED THROMBOLYTIC THERAPY BAKSHI, PANCHAM 1623 §112DP Final Rejection Pending Dec 08, 2022
17797682 REVERSE ELECTRO-OSMOTIC FILTRATION SYSTEM AND USES THEREOF KOLTONOW, ANDREW ROBERT 1700 §102§103§112 Non-Final OA Pending Aug 04, 2022

Managing UNIVERSITE PARIS CITE's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month